- English (USA)
- English (UK)
- English (India)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Eupraxia Pharmaceuticals Inc (EPRX)
Eupraxia Pharmaceuticals Inc stock price live, this page displays TSX EPRX stock exchange data. View the EPRX premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Eupraxia Pharmaceuticals Inc real time stock price chart below.
What Is the Eupraxia Pharmaceuticals Inc Stock Price Today?
The Eupraxia Pharmaceuticals Inc stock price today is 11.64.
What Is the Stock Symbol for Eupraxia Pharmaceuticals Inc?
The stock symbol for Eupraxia Pharmaceuticals Inc is "EPRX."
What Stock Exchange Does Eupraxia Pharmaceuticals Inc Trade On?
Eupraxia Pharmaceuticals Inc is listed and trades on the Toronto stock exchange.
Is Eupraxia Pharmaceuticals Inc a Good Stock to Buy?
Determining whether Eupraxia Pharmaceuticals Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the EPRX quote. (ISIN: CA29842P1053)
What Is the Eupraxia Pharmaceuticals Inc Stock Price Today?
The Eupraxia Pharmaceuticals Inc stock price today is 11.64.
What Is the Stock Symbol for Eupraxia Pharmaceuticals Inc?
The stock symbol for Eupraxia Pharmaceuticals Inc is "EPRX."
What Stock Exchange Does Eupraxia Pharmaceuticals Inc Trade On?
Eupraxia Pharmaceuticals Inc is listed and trades on the Toronto stock exchange.
Is Eupraxia Pharmaceuticals Inc a Good Stock to Buy?
Determining whether Eupraxia Pharmaceuticals Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the EPRX quote. (ISIN: CA29842P1053)
11.64
+1.28(+12.36%)
Closed·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
10.26
11.64
52 wk Range
7.15
12.86
EPRX is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
10.2611.64
52 wk Range
7.1512.86
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
EPRX Scorecard
Company’s Health
Assesses a company's financial position by analyzing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Buy
Analysts Sentiment
Strong Buy
Price Target
16.00
Upside
+37.46%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
8 analysts have revised their earnings downwards for the upcoming period
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy
Analyst Ratings
11 Buy
0 Hold
0 Sell
Ratings:
11 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 16.00
(+37.46% Upside)
Earnings
Latest Release
Aug 11, 2026
EPS / Forecast
-0.31 / -0.31
Revenue / Forecast
-- / --
Compare EPRX to Peers and Sector
Metrics to compare | EPRX | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipEPRXPeersSector | |
|---|---|---|---|---|
P/E Ratio | −10.5x | −6.8x | −0.4x | |
PEG Ratio | 0.58 | 0.03 | 0.00 | |
Price/Book | 5.5x | 1.7x | 2.6x | |
Price / LTM Sales | - | 3.0x | 3.0x | |
Upside (Analyst Target) | 54.4% | 84.1% | 48.7% | |
Fair Value Upside | Unlock | −19.3% | 7.0% | Unlock |
Eupraxia Pharmaceuticals Inc., a clinical-stage biotechnology company, focuses on the development of products to address therapeutic areas with unmet medical need. Its proprietary Diffusphere technology optimizes drug delivery for applications with significant unmet medical need. The company’s product portfolio includes EP-104IAR, which is in Phase III clinical trial for the treatment of knee osteoarthritis; EP-104GI that is in Phase II clinical trial for treating eosinophilic esophagitis; and EP-104, which is under preclinical studies for the treatment of gastrointestinal tract, such as eosinophilic esophagitis. The company was formerly known as Plaza Capital Partners Inc. and changed its name to Eupraxia Pharmaceuticals Inc. in May 2012. Eupraxia Pharmaceuticals Inc. was incorporated in 2011 and is headquartered in Victoria, Canada.
Ownership
Ownership Overview
Top Holders
People Also Watch
FAQ
What Is the Eupraxia Pharmaceuticals (EPRX) Stock Price Today?
The Eupraxia Pharmaceuticals stock price today is 11.64 CAD.
What Stock Exchange Does Eupraxia Pharmaceuticals Trade On?
Eupraxia Pharmaceuticals is listed and trades on the Toronto Stock Exchange.
What Is the Stock Symbol for Eupraxia Pharmaceuticals?
The stock symbol for Eupraxia Pharmaceuticals is "EPRX."
What Is the Eupraxia Pharmaceuticals Market Cap?
As of today, Eupraxia Pharmaceuticals market cap is 682.79M CAD.
What Is Eupraxia Pharmaceuticals's Earnings Per Share (TTM)?
The Eupraxia Pharmaceuticals EPS (TTM) is -1.00.
When Is the Next Eupraxia Pharmaceuticals Earnings Date?
Eupraxia Pharmaceuticals will release its next earnings report on Nov 11, 2026.
From a Technical Analysis Perspective, Is EPRX a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
How Many Times Has Eupraxia Pharmaceuticals Stock Split?
Eupraxia Pharmaceuticals has split 0 times.
What is the current trading status of Eupraxia Pharmaceuticals (EPRX)?
As of Sep 05, 2026, Eupraxia Pharmaceuticals (EPRX) is trading at a price of 11.64 CAD, with a previous close of 10.36 CAD. The stock has fluctuated within a day range of 10.26 CAD to 11.64 CAD, while its 52-week range spans from 7.15 CAD to 12.86 CAD.
What Is Eupraxia Pharmaceuticals (EPRX) Price Target According to Analysts?
The average 12-month price target for Eupraxia Pharmaceuticals is 16.00 CAD, with a high estimate of 18 CAD and a low estimate of 14 CAD. 11 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +37.46% Upside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.